Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.artemishospitals.com | |
Market Cap | 907.31 Cr. | |
Enterprise Value(EV) | 1,065.45 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.78 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 24.40 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 47.03 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 23.30 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 2.91 | Calculated using Price: 67.85 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 13.41 Cr. | 134,118,750 Shares |
FaceValue | 1 | |
Company Profile | ||
The Company is engaged in the business of managing and operating of multi specialty hospitals. |
1 Day |
|
-3.96% |
1 Week |
|
-6.80% |
1 Month |
|
-8.31% |
3 Month |
|
+7.02% |
6 Month |
|
+26.23% |
1 Year |
|
+55.62% |
2 Year |
|
+220.35% |
5 Year |
|
|
10 Year |
|
4 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 9.50 | 8.43 | 2.46 | 11.66 | |
Return on Capital Employed (%) | 13.96 | 12.64 | 5.63 | 11.47 | |
Return on Assets (%) | 3.68 | 3.41 | 1.03 | 4.70 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 293 | 313 | 320 | 359 | 379 | |
Non Curr. Liab. | 84 | 115 | 168 | 227 | 233 | |
Curr. Liab. | 177 | 158 | 118 | 138 | 189 | |
Minority Int. | 0 | 0 | 2 | 2 | 5 | |
Equity & Liab. | 554 | 586 | 609 | 726 | 806 | |
Non Curr. Assets | 442 | 469 | 499 | 599 | 640 | |
Curr. Assets | 113 | 118 | 109 | 127 | 166 | |
Misc. Exp. not W/O | ||||||
Total Assets | 554 | 586 | 609 | 726 | 806 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 547 | 565 | 408 | 555 | 648 | |
Other Income | 4 | 5 | 4 | 4 | 6 | |
Total Income | 551 | 570 | 412 | 559 | 654 | |
Total Expenditure | -483 | -504 | -373 | -487 | -571 | |
PBIDT | 68 | 66 | 39 | 71 | 83 | |
Interest | -11 | -13 | -13 | -12 | -16 | |
Depreciation | -20 | -23 | -22 | -22 | -26 | |
Taxation | -16 | -11 | -1 | -6 | -5 | |
Exceptional Items | 3 | |||||
PAT | 20 | 19 | 6 | 31 | 37 | |
Minority Interest | 0 | 0 | 0 | 0 | 1 | |
Share Associate | ||||||
Other Related Items | ||||||
Consolidated Net Profit | 20 | 20 | 6 | 32 | 37 | |
Adjusted EPS | 2 | 0 | 2 | 3 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 40 | 56 | 27 | 60 | |
Cash Fr. Inv. | -50 | -26 | -37 | -107 | |
Cash Fr. Finan. | 14 | -27 | 18 | 44 | |
Net Change | 5 | 2 | 8 | -3 | |
Cash & Cash Eqvt | 9 | 12 | 19 | 16 |
Wed, 25 Jan 2023
Board Meeting Intimation for Board Meeting Intimation For Quarterly Results Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve In pursuance of Regulation 29 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on February 1 2023 (Wednesday) inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/nine months period ended December 31 2022.As informed by our communication dated December 30 2022 the trading window for dealing in securities of the Company was closed from January 1 2023 and shall remain closed till 48 hours after the declaration of financial results i.e. up to February 3 2023 (both days inclusive). |
Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 we are enclosing herewith the certificate issued by Alankit Assignments Limited Registrar and Transfer Agent of the Company confirming the compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022. |
Fri, 30 Dec 2022
Closure of Trading Window It is hereby informed that in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and pursuant to the Companys Code of Conduct to Regulate Monitor and Report Trading in the securities of the Company by Designated Persons and their Immediate Relatives the trading window for trading in securities of the Company shall remain closed for all Concerned Persons with effect from January 1 2023 till 48 hours after the declaration of financial results of the Company for the quarter ending December 31 2022. |
Fri, 27 Jan 2023 |
|
|
|
|
|